Phenytoin and levetiracetam are equally effective second-line treatments for status epilepticus

Affiliations

Comment

Rebecca Amy Dalrymple. Arch Dis Child Educ Pract Ed. 2020 Oct.

. 2020 Oct;105(5):319-320.

doi: 10.1136/archdischild-2019-318038. Epub 2019 Dec 11.

¹ Department of General Paediatrics, Royal Hospital for Children Glasgow, Glasgow G83 0UA, UK rebecca.dalrymple1@nhs.net.

No abstract available

Keywords: epilepsy; levetiracetam; phenytoin; status epilepticus.

Comment on

Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.
Lyttle MD, Rainford NEA, Gamble C, Messahel S, Humphreys A, Hickey H, Woolfall K, Roper L, Noblet J, Lee ED, Potter S, Tate P, Iyer A, Evans V, Appleton RE; Paediatric Emergency Research in the United Kingdom & Ireland (PERUKI) collaborative. Lyttle MD, et al. Lancet. 2019 May 25;393(10186):2125-2134. doi: 10.1016/S0140-6736(19)30724-X. Epub 2019 Apr 17. Lancet. 2019. PMID: 31005385 Free PMC article. Clinical Trial.
Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.
Dalziel SR, Borland ML, Furyk J, Bonisch M, Neutze J, Donath S, Francis KL, Sharpe C, Harvey AS, Davidson A, Craig S, Phillips N, George S, Rao A, Cheng N, Zhang M, Kochar A, Brabyn C, Oakley E, Babl FE; PREDICT research network. Dalziel SR, et al. Lancet. 2019 May 25;393(10186):2135-2145. doi: 10.1016/S0140-6736(19)30722-6. Epub 2019 Apr 17. Lancet. 2019. PMID: 31005386 Clinical Trial.